Webinar | January 6, 2021

IND Best Practices: 5 Tips For A Successful Filing

Source: Egnyte

There are many steps that need to be performed in order to assemble an Investigational New Drug (IND) Application. Whether it be consulting with the FDA, using a GxP compliant collaboration platform, or finding a partner, this process is often complex. Despite the numerous steps, it does not have to be an insurmountable goal.

In this webinar, Egnyte’s Life Sciences Director of Product Management, Harith Kesari, reviews 5 key best practices for assembling your IND. With over 20+ years working at the intersection of clinical development, regulatory affairs, and software, Harith identifies specific tips that you can integrate into your workflow today.

In this session, you will learn:

  • Structured content authoring methodology
  • GxP compliant tools for collaboration
  • How to engage with the FDA
access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Egnyte